InicioABUS • NASDAQ
add
Arbutus Biopharma Corp
Cierre anterior
4,26 $
Intervalo anual
2,71 $ - 5,10 $
Cap. bursátil
819,30 M USD
Volumen medio
2,67 M
Relación precio-beneficio
-
Rentabilidad por dividendo
-
Bolsa de valores principal
NASDAQ
Noticias sobre los mercados
Información sobre la empresa
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Director ejecutivo
Fundación
2007
Sitio web
Empleados
44
